October 17, 2023 06:25 PM EDTUpdated October 18, 03:03 PM
Startups
Deals
Pharma

Scoop: Eli Lil­ly agrees to ac­quire an­oth­er Eu­ro­pean ADC biotech

Kyle LaHucik

Senior Reporter

Eli Lil­ly has agreed to ac­quire an­oth­er an­ti­body-drug con­ju­gate biotech, swoop­ing in for France-based Mablink Bio­science, End­points News has learned. The Sofinno­va-backed start­up is a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times